AFYREN's proprietary fermentation process transforms agricultural by-products into seven high-value organic acids through a circular, waste-free process with significantly lower carbon footprint than traditional petrochemical alternatives. The company achieved industrial continuous running of its plant and has commercialized over 100 tons of bio-based acids for several clients.
Cyborg Score Rationale
AFYREN has a solid cash position of €27.5 million as of June 30, 2025, with stable cash consumption and plant breakeven expected within a few quarters. However, the company is still in early commercialization phase with modest revenue and faces competition from established petrochemical players with cost advantages.
Top Insights
Industrial continuous running of plant achieved with hundreds of tons of bio-based acids produced and over 100 tons commercialized
Company is expanding internationally with second facility under development in Thailand